Biological characterization of angiopoietin‐3 and angiopoietin‐4
- 4 June 2004
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 18 (11) , 1200-1208
- https://doi.org/10.1096/fj.03-1466com
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Differential regulation of VEGF, HIF1α and angiopoietin‐1, ‐2 and ‐4 by hypoxia and ionizing radiation in human glioblastomaInternational Journal of Cancer, 2003
- Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cellsBritish Journal of Pharmacology, 2003
- Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel‐Lindau gene and hypoxiaThe Journal of Pathology, 2002
- Impairment of Store-Operated Ca 2+ Entry in TRPC4 −/− Mice Interferes With Increase in Lung Microvascular PermeabilityCirculation Research, 2002
- EphB ligand, ephrinB2, suppresses the VEGF‐ and angiopoietin‐1‐induced Ras/mitogen‐activated protein kinase pathway in venous endothelial cellsThe FASEB Journal, 2002
- Biomedical significance of endothelial cell specific growth factor, angiopoietinExperimental & Molecular Medicine, 2002
- The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular developmentSeminars in Cell & Developmental Biology, 2002
- The angiopoietin–tie2 system in coronary artery endothelium prevents oxidized low-density lipoprotein-induced apoptosisCardiovascular Research, 2001
- Expression of Tie1, Tie2, and Angiopoietins 1, 2, and 4 in Kaposi's Sarcoma and Cutaneous AngiosarcomaThe American Journal of Pathology, 2000
- Identification of Tek/Tie2 Binding PartnersJournal of Biological Chemistry, 1999